SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-252927
Filing Date
2017-08-09
Accepted
2017-08-09 17:05:55
Documents
75
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d313382d10q.htm 10-Q 509041
2 EX-31.1 d313382dex311.htm EX-31.1 6383
3 EX-31.2 d313382dex312.htm EX-31.2 6412
4 EX-32.1 d313382dex321.htm EX-32.1 2924
5 EX-32.2 d313382dex322.htm EX-32.2 2964
  Complete submission text file 0001193125-17-252927.txt   3854037

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bdsi-20170630.xml EX-101.INS 596930
7 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20170630.xsd EX-101.SCH 59877
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdsi-20170630_cal.xml EX-101.CAL 71938
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdsi-20170630_def.xml EX-101.DEF 197375
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20170630_lab.xml EX-101.LAB 425193
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20170630_pre.xml EX-101.PRE 320241
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 171018770
SIC: 2834 Pharmaceutical Preparations